We are all porters
Release time:
2022-07-24
7# January 15 , at 7: 30 a.m., Wu Weisheng, general manager of Jinhua pharmaceutical company, stood at the gate with frowning brows. an ultra-long truck with a length of 25 meters and a height of 5 meters stopped beside him. the truck was a large infusion that had just arrived, with nearly 2500 pieces. Because the height limit of the warehouse is 4.5 meters, this large truck cannot enter the unloading area, how should this whole truck be unloaded?
The weather in Jinhua is hot recently. The temperature can reach 40 degrees on that day. If the medicine is exposed to the hot sun all the time, there will be a risk of affecting the quality of the medicine. 2500 pieces must be unloaded before 12 , so this is undoubtedly a race against time. When the employees saw it at work, they helped to give advice and everyone said they could help unload the goods together.
Wu Weisheng made a decisive decision and decided to mobilize the entire pharmaceutical company to unload the goods by car ferry. First, the goods were unloaded onto the minivan and then pulled to the unloading area for storage. It's not too late, just do what you say! Under the leadership of Wu Weisheng, Li Anhua and other team members, the employees also put down their work and came to help. There were employees from the business department, the storage department, and the administrative logistics department. Almost every department came. There were both party members and non-party members, but at that time, everyone had only one identity, that is, employees of Jinhua Pharmaceutical Company. Everyone has only one goal, that is, to load and unload all the goods before 12 .
Unity is efficiency. Car after car, the clothes on the employees were wet and dry, dry and wet, but without a word of complaint, everyone worked together and finally unloaded all the goods at 11: 40 on . Looking at the long car empty, the driver from the northeast also gave the employees a thumbs up: "I thought it would take the afternoon to finish unloading and the evening to leave. I didn't expect your efficiency to be so high, so fast and powerful! "
"The timely storage and distribution of drug logistics, as well as the quality and safety of drugs, are all related to the health of patients' medication. Our improvement of efficiency is undoubtedly to help hospitals improve efficiency and buy more time for patients. All employees of our pharmaceutical company should not only do their own work well, but also bear more social responsibilities behind the work. I am proud and proud of the entire staff of the pharmaceutical company. " After loading and unloading the goods, Wu Weisheng's frown stretched and finally showed a bright smile.
(Shengda)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page